Natale Quartuccio

ORCID: 0000-0001-9845-1384
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Medical Imaging Techniques and Applications
  • Radiomics and Machine Learning in Medical Imaging
  • Glioma Diagnosis and Treatment
  • Cancer, Hypoxia, and Metabolism
  • Sarcoma Diagnosis and Treatment
  • Neuroblastoma Research and Treatments
  • Lung Cancer Treatments and Mutations
  • Radiopharmaceutical Chemistry and Applications
  • Neuroendocrine Tumor Research Advances
  • Breast Cancer Treatment Studies
  • Hematological disorders and diagnostics
  • Lung Cancer Research Studies
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Cancer Diagnosis and Treatment
  • Bone Tumor Diagnosis and Treatments
  • Medical Imaging and Pathology Studies
  • Thyroid Cancer Diagnosis and Treatment
  • Ovarian cancer diagnosis and treatment
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Peptidase Inhibition and Analysis
  • Lung Cancer Diagnosis and Treatment
  • Orthopedic Infections and Treatments
  • Lymphoma Diagnosis and Treatment
  • COVID-19 and healthcare impacts
  • Adrenal and Paraganglionic Tumors

Ospedale Vincenzo Cervello
2022-2024

Società Italiana di Medicina Generale
2021-2023

Azienda di Rilievo Nazionale ed Alta Specializzazione
2018-2023

University of Ferrara
2023

University of Padua
2023

Cognitive Neuroimaging Lab
2021

University of Manchester
2016-2018

University of Messina
2012-2017

University Hospital of Basel
2016

Ospedale Garibaldi
2016

The purpose of this study was to compare the diagnostic performance (18)F-FDG PET/CT and conventional imaging for staging follow-up pediatric osteosarcoma skeletal Ewing sarcoma.We calculated sensitivity, specificity, accuracy (CT, MRI, bone scanning) sites disease number lesions. Diagnostic benefit, defined as better characterization lesions, evaluated on a per-scan basis, comparing imaging.A total 412 lesions were characterized by in 64 patients (20, osteosarcoma; 44, sarcoma). For...

10.2214/ajr.14.12932 article EN American Journal of Roentgenology 2014-12-24

The objective of this study is to systematically review the role positron emission tomography (PET) and PET/computed (PET/CT) with Fluorine-18-Fluorodeoxyglucose (FDG) in patients osteosarcoma (OS).A comprehensive literature search published studies through October 10(th), 2012 PubMed/MEDLINE, Embase Scopus databases regarding whole-body FDG-PET FDG-PET/CT OS was performed.We identified 13 including 289 OS. With regard staging restaging OS, diagnostic performance PET/CT seem be high;...

10.2478/raon-2013-0017 article EN cc-by-nc-nd Radiology and Oncology 2013-02-22

Neuroblastoma is the most common extra-cranial solid tumor in pediatric patients. Despite established role of 123I-MIBG and 131I-MIBG scintigraphy this tumor, only limited data are available regarding use 124I-metaiodobenzylguanidine (MIBG) positron emission tomography (PET)/computed (CT). We present our preliminary experience with 124I-MIBG PET/CT: two patients affected by neuroblastoma, who underwent PET/CT for pre-therapy distribution evaluation restaging purposes. aimed to evaluate...

10.5603/nmr.2015.0024 article EN cc-by-nc-nd Nuclear Medicine Review 2015-07-31

Early in-vivo diagnosis of Alzheimer's disease (AD) is crucial for accurate management patients, in particular, to select subjects with mild cognitive impairment (MCI) that may evolve into AD, and define other types MCI non-AD patients. The application artificial intelligence functional brain [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography(CT) aiming increase diagnostic accuracy the AD still undetermined. In this field, we propose a radiomics analysis on...

10.3390/diagnostics12040933 article EN cc-by Diagnostics 2022-04-08

Pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) is a strong prognostic factor in breast cancer (BC). The aim of this study was to investigate whether semiquantitative parameters derived from baseline [18F]Fluorodeoxyglucose ([18F]FDG) positron emission computed tomography/computed tomography (PET/CT) could predict pCR NAC and survival outcomes patients affected by different molecular subtypes BC. We retrospectively retrieved the databases two Italian hospitals...

10.3390/cancers14235869 article EN Cancers 2022-11-29

Background: The aim of this study was to investigate whether high body mass index (BMI) increases the risk recurrence and correlates with higher glucose uptake in recurrent lesions post-menopausal female patients breast cancer. Methods: A hospital database searched retrieve cancer who had undergone an [18F]FDG PET/CT scan before neoadjuvant chemotherapy curative-intent surgery. BMI calculated at baseline scan. There a median follow-up 5 years after identify (T_rec); lymph nodes (N_rec);...

10.3390/jcm13061575 article EN Journal of Clinical Medicine 2024-03-09

The purpose of the study was to evaluate correlation between maximum standardized uptake value (SUVmax), size primary lung lesion, disease-free survival (DFS) and overall (OS) in patients with stage I II non-small cell cancer (NSCLC) 2 years follow-up.Forty-nine I-II NSCLC were included this study. Pre-surgical 2-deoxy-2-[18F]fluoro-D-glucose positron-emission tomography ((18)F-FDG PET/CT) performed for all patients. relationship SUVmax, tumour clinical outcome measured. cut-off SUVmax best...

10.2478/raon-2013-0023 article EN cc-by-nc-nd Radiology and Oncology 2013-04-15

To evaluate the diagnostic and prognostic role of fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) in comparison to morphological imaging such as computed primary adrenal malignancies.In this multicenter retrospective study, 68 patients with malignancy were included. All had histologically proven diagnosis (adrenocortical carcinoma, malignant pheochromocytoma, neuroblastoma lymphoma), one whole body (18)F-FDG PET/CT scan whole-body...

10.1967/s002449910202 article EN PubMed 2015-07-19

This multicentric study aimed to investigate the main prognostic factors associated with treatment response at 1 year after radioactive iodine therapy (RAIT) and last disease status in pediatric patients affected by differentiated thyroid carcinoma (DTC).

10.1007/s00259-021-05586-8 article EN cc-by European Journal of Nuclear Medicine and Molecular Imaging 2021-10-19
Coming Soon ...